Advancing Exceptional Research on HIV/AIDS and Substance Abuse (RFA-DA-15-005)
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Individual researchers and research teams
Geography
- Geographic Scope: Not specified (appears to be US-based NIH funding)
Other requirements
- Not limited to any one area of research on HIV and substance use
Overview
Purpose: To support highly innovative research projects that address a biomedical or behavioral issue relevant to HIV and drug abuse and/or lead to new avenues of research or new interventions for prevention and treatment of HIV/AIDS among substance abusers.
Eligibility:
- Open to individual researchers and research teams
- Not limited to any one area of research on HIV and substance use
Geographic Scope: Not specified (appears to be US-based NIH funding)
Focus Areas:
- Biomedical research on HIV and drug abuse
- Behavioral research on HIV and substance use
- New interventions for prevention and treatment of HIV/AIDS among substance abusers
What AIDS Vaccine Advocacy Coalition Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 4
- Total given
- $1.04M
- Median grant
- $193K
- Range
- $98K–$555K
- By dollars: Massachusetts 53%, New York 22%, North Carolina 15%. Top recipient cities: Boston, MA; New York, NY; Durham, NC.
Example grants
Clinton Health Access Initiative · Boston, MA
To create a platform
$555K
International AIDS Vaccine Initiative · New York, NY
Hiv vaccine and biom
$227K
Family Health International 360 · Durham, NC
Hiv vaccine and biom
$160K
Internews · Arcata, CA
Hiv vaccine and biom
$98K
Focus Areas & Funding Uses
Fields of Work
- HIV/AIDS
- Addiction recovery
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)
AIDS Vaccine Advocacy Coalition Inc
Amount
Varies
Deadline
Deadline not published
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $1,500,000
Deadline
March 5, 2027
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
March 6, 2027
Mapplethorpe Foundation Grants: HIV/AIDS Research
The Robert Mapplethorpe Foundation Inc
Amount
Varies
Deadline
Deadline not published
Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $450K
Deadline
July 16, 2029
APBD Research Foundation Rally for Research Pilot Grant Program
Apbd Research Foundation
Amount
Varies
Deadline
Deadline not published
Ready to apply for Advancing Exceptional Research on HIV/AIDS and Substance Abuse (RFA-DA-15-005)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Advancing Exceptional Research on HIV/AIDS and Substance Abuse (RFA-DA-15-005). Now let's win it.